TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
21 hedge funds and large institutions have $2.65M invested in Titan Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$51.1K | |
| 2 | +$22K | |
| 3 | +$11.6K | |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$3K |
| 5 |
FHA
Flagship Harbor Advisors
Boston,
Massachusetts
|
+$2K |
Top Sellers
| 1 | -$80K | |
| 2 | -$52K | |
| 3 | -$46.7K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$39K |
| 5 |
SRAM
Stone Ridge Asset Management
New York
|
-$30K |